Plain-English translation of NCT06238765 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This is a long-term study that follows teenagers (ages 12–15) with moderate to severe atopic dermatitis (eczema) who are starting a new approved medication for their condition. Researchers will collect information about how well the medication works, any side effects that occur, and how it affects daily life. The goal is to build a detailed picture of what happens when teenagers take these medications in real-world settings, not just in controlled clinical trials.
Doctors and medication companies need real-world information about how these treatments perform in everyday life, including long-term safety and how well they actually help teenagers manage their eczema. This study will help future patients and doctors make better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would visit your dermatologist or skin care provider at regular intervals over a period of time while taking your new medication. At these visits, the research team will ask you questions about how you're doing, check how your skin is responding, and collect information about any side effects or other health changes. They'll also use standard questionnaires to track your skin symptoms and how the condition affects your daily life—things like sleep, schoolwork, and socializing.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
CorEvitas
Enrollment target
~1,500 participants
Started
December 2023
Primary completion
December 2099
Age range
12 Years – 15 Years
Last updated on clinicaltrials.gov in February 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.